Access
To read this story in full you will need to login or make a payment (see right).
Insight
Nature 441, 1100-1102 (29 June 2006) | doi:10.1038/nature04962; Published online 28 June 2006
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
- More Challenges
- Powered by:
nature jobs
Professorship in Functional Genomics of Fungi
- University of Natural Resources and Applied Life Sciences Vienna
- Vienna 1190 Austria
Sensory Scientist
- Philip Morris International (PMI)
- Neuchatel, Switzerland
Progress Stem-cell therapies for blood diseases
Claudio Bordignon1
Abstract
For decades, transplantation of haematopoietic stem cells — either unmodified, or genetically modified to correct genetic disorders — has been used to treat disorders of the blood and immune systems. The present challenge is to reduce the risk of such transplants and increase the number of patients who can safely access this treatment. In developing countries, such 'one-shot' treatments are highly desirable because chronic treatments are difficult to sustain. To make these therapies more accessible and effective it will be important to improve clinical protocols and gene-delivery vectors, and to gain a deeper understanding of stem cells.
To read this story in full you will need to login or make a payment (see right).
